Microbubbles as ultrasound contrast agents for molecular imaging: Preparation and application

American Journal of Roentgenology

Volumn 199, Issue 2, 2012, Pages 292-299

  Unnikrishnan, Sunil ^a   Klibanov, Alexander L ^a  

^a University of Virginia   (United States)

Author keywords

Angiogenesis; Contrast agents; Inflammation; Microbubbles; Molecular imaging; Ultrasound

Indexed keywords

BIOTIN; BR 55; ECHO CONTRAST MEDIUM; INTERCELLULAR ADHESION MOLECULE 1; MACROGOL; MP 1950; PADGEM PROTEIN; PERFLEXANE; PERFLUBUTANE; PERFLUTREN; SHU 508; SONOVIST; SONOVUE; SONOVUST; STREPTAVIDIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN RECEPTOR 2; VITRONECTIN RECEPTOR;

ADHESION; AQUEOUS SOLUTION; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOTINYLATION; CONJUGATION; CONTRAST ENHANCEMENT; DRUG DOSE COMPARISON; ENTERITIS; HALF LIFE TIME; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATION; KIDNEY ISCHEMIA; MICROBUBBLE; MOLECULAR IMAGING; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSTATE CANCER; REPERFUSION INJURY; REVIEW; TUMOR GROWTH; TUMOR VASCULARIZATION; ULTRASOUND TRANSDUCER; VASCULAR ENDOTHELIUM;

CONTRAST MEDIA; HUMANS; MICROBUBBLES; MOLECULAR IMAGING; ULTRASONOGRAPHY;

EID: 84864740638     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.12.8826     Document Type: Review

References (75)

1. Dietrich CF, Kratzer W, Strobe D, et al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 2006; 12:1699-1705
2. Hatanaka K, Kudo M, Minami Y, Maekawa K. Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT. Oncology 2008; 75(suppl 1):42-47
3. Feinstein SB. Contrast ultrasound imaging of the carotid artery vasa vasorum and atherosclerotic plaque neovascularization. J Am Coll Cardiol 2006; 48:236-243
4. Vicenzini E, Giannoni MF, Puccinelli F, et al. Detection of carotid adventitial vasa vasorum and plaque vascularization with ultrasound cadence contrast pulse sequencing technique and echocontrast agent. Stroke 2007; 38:2841-2843 (Pubitemid 47494026)
5. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998; 97:473-483 (Pubitemid 28090220)
6. Senior R, Monaghan M, Main ML, et al. Detection of coronary artery disease with perfusion stress echocardiography using a novel ultrasound imaging agent: two phase 3 international trials in comparison with radionuclide perfusion imaging. Eur J Echocardiogr 2009; 10:26-35
7. Stride E. Physical principles of microbubbles for ultrasound imaging and therapy. Cerebrovasc Dis 2009; 27(suppl 2):1-13
8. Klibanov AL, Rasche PT, Hughes MS, et al. Detection of individual microbubbles of ultrasound contrast agents: imaging of free-floating and targeted bubbles. Invest Radiol 2004; 39:187-195 (Pubitemid 38263925)
9. Mor-Avi V, Caiani EG, Collins KA, Korcarz CE, Bednarz JE, Lang RM. Combined assessment of myocardial perfusion and regional left ventricular function by analysis of contrast-enhanced power modulation images. Circulation 2001; 104:352-357 (Pubitemid 32666960)
10. Haider B, Chiao RY. Higher order nonlinear ultrasonic imaging. Proc IEEE Ultrason Symp 1999; 2:1527-1531
11. Phillips P. Contrast pulse sequences (CPS): imaging nonlinear microbubbles. Proc IEEE Ultrason Symp 2001; 2:1739-1745
12. Epstein P, Plesset M. On the stability of gas bubbles in liquid-gas solutions. J Chem Phys 1950; 18:1505-1509
13. Keller MW, Segal SS, Kaul S, Duling B. The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography. Circ Res 1989; 65:458-467 (Pubitemid 19194632)
14. Otis S, Rush M, Boyajian R. Contrast-enhanced transcranial imaging: results of an American phase-two study. Stroke 1995; 26:203-209
15. Klibanov AL. Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv Drug Deliv Rev 1999; 37:139-157 (Pubitemid 29164505)
16. de Jong N, Emmer M, van Wamel A, Versluis M. Ultrasonic characterization of ultrasound contrast agents. Med Biol Eng Comput 2009; 47:861-873
17. Bzyl J, Lederle W, Rix A, et al. Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38). Eur Radiol 2011; 21:1988-1995
18. Unger E, Fritz T, Matsunaga T, et al. Method of preparing gas and gaseous precursor-filled microspheres. U. S. patent 5,585,112. December 17, 1996
19. Della Martina A, Allemann E, Bettinger T, et al. Grafting of abciximab to a microbubble-based ultrasound contrast agent for targeting to platelets expressing GP IIb/IIIa - characterization and in vitro testing. Eur J Pharm Biopharm 2008; 68:555-564 (Pubitemid 351318198)
20. Böhmer MR, Schroeders R, Steenbakkers JA, et al. Preparation of monodisperse polymer particles and capsules by ink-jet printing. Colloids Surf A Physicochem Eng Asp 2006; 289:96-104 (Pubitemid 44441878)
21. Narayan P, Wheatley MA. Preparation and characterization of hollow microcapsules for use as ultrasound contrast agents. Polym Eng Sci 1999; 39:2242-2255 (Pubitemid 30528034)
22. Lukáč R, Kauerová Z, Mašek J, et al. Preparation of metallochelating microbubbles and study on their site-specific interaction with rGFP-HisTag as a model protein. Langmuir 2011; 27:4829-4837
23. Villanueva FS, Jankowski RJ, Klibanov S, et al. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation 1998; 98:1-5 (Pubitemid 28312070)
24. Klibanov AL. Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging. Bioconjug Chem 2005; 16:9-17 (Pubitemid 40129671)
25. Jeppesen C, Wong JY, Kuhl TL, et al. Impact of polymer tether length on multiple ligand-receptor bond formation. Science 2001; 293:465-468 (Pubitemid 32679068)
26. Lee RJ, Low PS. Folate-mediated tumor-cell targeting of liposome-entrapped doxorubicin in vitro. Biochim Biophys Acta 1995; 1233:134-144
27. Kim DH, Klibanov AL, Needham D. The influence of tiered layers of surface-grafted poly(ethylene glycol) on receptor-ligand-mediated adhesion between phospholipid monolayer-stabilized microbubbles and coated class beads. Langmuir 2000; 16:2808-2817 (Pubitemid 30576809)
28. Ham AS, Klibanov AL, Lawrence MB. Action at a distance: lengthening adhesion bonds with poly (ethylene glycol) spacers enhances mechanically stressed affinity for improved vascular targeting of microparticles. Langmuir 2009; 25:10038-10044
29. Pillai R, Marinelli ER, Fan H, et al. A phospholipid-PEG2000 conjugate of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeting heterodimer peptide for contrast-enhanced ultrasound imaging of angiogenesis. Bioconjug Chem 2010 Feb 19 [Epub ahead of print]
30. Hutter JC, Luu HM, Mehlhaff PM, Killam AL, Dittrich HC. Physiologically based pharmacokinetic model for fluorocarbon elimination after the administration of an octafluoropropane-albumin microsphere sonographic contrast agent. J Ultrasound Med 1999; 18:1-11 (Pubitemid 29024470)
31. Walday P, Tolleshaug H, Gjoen T, et al. Biodistributions of air-filled albumin microspheres in rats and pigs. Biochem J 1994; 299:437-443 (Pubitemid 24114137)
32. Perkins AC, Frier M, Hindle AJ, et al. Human biodistribution of an ultrasound contrast agent (Quantison) by radiolabelling and gamma scintigraphy. Br J Radiol 1997; 70:603-611 (Pubitemid 27285617)
33. Jakobsen JA, Oyen R, Thomsen HS, Morcos SK. Safety of ultrasound contrast agents. Eur Radiol 2005; 15:941-945 (Pubitemid 41174436)
34. Piscaglia F, Bolondi L. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 2006; 32:1369-1375 (Pubitemid 44332662)
35. Main ML, Ryan AC, Davis TE, Albano MP, Kusnetzky LL, Hibberd M. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients). Am J Cardiol 2008; 102:1742-1746
36. Pochon S, Tardy I, Bussat P, et al. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol 2010; 45:89-95
37. Takalkar AM, Klibanov AL, Rychak JJ, Lindner JR, Ley K. Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. J Control Release 2004; 96:473-482 (Pubitemid 38553925)
38. Rychak JJ, Li B, Acton ST, et al. Selectin ligands promote ultrasound contrast agent adhesion under shear flow. Mol Pharm 2006; 3:516-524 (Pubitemid 44639128)
39. Weller GER, Villanueva FS, Tom EM, Wagner WR. Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewis. Biotechnol Bioeng 2005; 92:780-788 (Pubitemid 41772473)
40. Ferrante EA, Pickard JE, Rychak J, Klibanov A, Ley K. Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow. J Control Release 2009; 140:100-107
41. Lindner JR, Coggins MP, Kaul S, Klibanov AL, Brandenburger GH, Ley K. Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrinand complement-mediated adherence to activated leukocytes. Circulation 2000; 101:668-675 (Pubitemid 30094739)
42. Lindner JR, Dayton PA, Coggins MP, et al. Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation 2000; 102:531-538 (Pubitemid 30639971)
43. Fisher NG, Christiansen JP, Klibanov A, Taylor RP, Kaul S, Lindner JR. Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement. J Am Coll Cardiol 2002; 40:811-819 (Pubitemid 34925631)
44. Lindner JR, Song J, Xu F, et al. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation 2000; 102:2745-2750
45. Christiansen JP, Leong-Poi H, Klibanov AL, Kaul S, Lindner JR. Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation 2002; 105:1764-1767 (Pubitemid 34408882)
46. Moriyasu F, Itoh K. Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial. AJR 2009; 193:86-95
47. Kaufmann BA, Sanders JM, Davis C, et al. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation 2007; 116:276-284 (Pubitemid 47196563)
48. Kaufmann BA, Carr CL, Belcik JT, et al. Molecular imaging of the initial inflammatory response in atherosclerosis implications for early detection of disease. Arterioscler Thromb Vasc Biol 2010; 30:54-59
49. Kaufmann BA, Lewis C, Xie A, Mirza-Mohd A, Lindner JR. Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography. Eur Heart J 2007; 28:2011-2017 (Pubitemid 47591499)
50. Lindner JR, Song J, Christiansen J, Klibanov AL, Xu F, Ley K. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 2001; 104:2107-2112 (Pubitemid 33027054)
51. Bachmann C, Klibanov AL, Olson TS, et al. Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease. Gastroenterology 2006; 130:8-16 (Pubitemid 43049830)
52. Deshpande N, Lutz AM, Ren Y, et al. Quantification and monitoring of inflammation in murine inflammatory bowel disease with targeted contrast-enhanced US. Radiology 2012; 262:172-180
53. Hernot S, Unnikrishnan S, Du Z, et al. Nanobody-coupled microbubbles as novel molecular tracer. J Control Release 2012; 158:346-353
54. Ellegala DB, Leong-Poi H, Carpenter JE, et al. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v) beta3. Circulation 2003; 108:336-341 (Pubitemid 36899026)
55. Anderson CR, Hu X, Zhang H, et al. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. Invest Radiol 2011; 46:215-224
56. Willmann JK, Kimura RH, Deshpande N, Lutz AM, Cochran JR, Gambhir SS. Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides. J Nucl Med 2010; 51:433-440
57. Willmann JK, Paulmurugan R, Chen K, et al. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 2008; 246:508-518
58. Anderson CR, Rychak JJ, Backer M, Backer J, Ley K, Klibanov AL. scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis. Invest Radiol 2010; 45:579-585
59. Pysz MA, Foygel K, Rosenberg J, Gambhir SS, Schneider M, Willmann JK. Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). Radiology 2010; 256:519-527
60. Willmann JK, Lutz AM, Paulmurugan R, et al. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. Radiology 2008; 248:936-944
61. Warram JM, Sorace AG, Saini R, Umphrey HR, Zinn KR, Hoyt K. A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature. J Ultrasound Med 2011; 30:921-931
62. Leong-Poi H, Christiansen J, Heppner P, et al. Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circulation 2005; 111:3248-3254 (Pubitemid 40874997)
63. Wright WH, McCreery TP, Krupinski EA, et al. Evaluation of new thrombus-specific ultrasound contrast agent. Acad Radiol 1998; 5:S240-S242
64. Wu Y, Unger EC, McCreery TP, et al. Binding and lysing of blood clots using MRX-408. Invest Radiol 1998; 33:880-885 (Pubitemid 30247060)
65. Unger E, Metzger P, Krupinski E, et al. The use of a thrombus-specific ultrasound contrast agent to detect thrombus in arteriovenous fistulae. Invest Radiol 2000; 35:86-89 (Pubitemid 30033611)
66. Schumann PA, Christiansen JP, Quigley RM, et al. Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol 2002; 37:587-593 (Pubitemid 35231692)
67. Martin MJ, Chung EM, Goodall AH, et al. Enhanced detection of thromboemboli with the use of targeted microbubbles. Stroke 2007; 38:2726-2732 (Pubitemid 47494010)
68. Guenther F, von zur Muhlen C, Ferrante EA, Grundmann S, Bode C, Klibanov AL. An ultrasound contrast agent targeted to P-selectin detects activated platelets at supra-arterial shear flow conditions. Invest Radiol 2010; 45:586-591
69. Villanueva FS, Lu E, Bowry S, et al. Myocardial ischemic memory imaging with molecular echocardiography. Circulation 2007; 115:345-352 (Pubitemid 46151660)
70. Dayton PA, Morgan KE, Klibanov AL, Branden burger G, Nightingale KR, Ferrara KW. A preliminary evaluation of the effects of primary and secondary radiation forces on acoustic contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 1997; 44:1264-1277 (Pubitemid 127771321)
71. Dayton P, Klibanov A, Brandenburger G, Ferrara K. Acoustic radiation force in vivo: a mechanism to assist targeting of microbubbles. Ultrasound Med Biol 1999; 25:1195-1201 (Pubitemid 29465793)
72. Zhao S, Borden M, Bloch SH, Kruse D, Ferrara KW, Dayton PA. Radiation-force assisted targeting facilitates ultrasonic molecular imaging. Mol Imaging 2004; 3:135-148
73. Rychak JJ, Klibanov AL, Hossack JA. Acoustic radiation force enhances targeted delivery of ultrasound contrast microbubbles: in vitro verification. IEEE Trans Ultrason Ferroelectr Freq Control 2005; 52:421-433
74. Rychak JJ, Klibanov AL, Ley KF, Hossack JA. Enhanced targeting of ultrasound contrast agents using acoustic radiation force. Ultrasound Med Biol 2007; 33:1132-1139 (Pubitemid 47002129)
75. Chen CC, Sirsi SR, Homma S, Borden MA. Effect of surface architecture on in vivo ultrasound contrast persistence of targeted size-selected microbubbles. Ultrasound Med Biol 2012; 38:492-503